Skyward Specialty director granted 3,890 RSUs

Peirce Christopher Locke reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Peirce Christopher Locke reported acquisition or exercise transactions in this Form 4 filing.

Skyward Specialty Insurance Group, Inc. director Christopher Locke received a grant of 3,890 restricted stock units (RSUs). Each RSU represents the right to receive one share of the company’s common stock after vesting and settlement.

The award was granted on May 6, 2026 and is scheduled to fully vest on the date of the company’s 2027 Annual Meeting of Shareholders, subject to the terms of the award agreement. Following the reported transactions, Locke holds 3,200 shares of common stock directly and 3,890 RSUs tied to common stock.

Insider Trade Summary

Grant/Award: 3,890 shares

Grant/Award 2 txns

Insider Peirce Christopher Locke

Role Director

Type	Security	Shares	Price	Value
Grant/Award	2026 RSU Award	3,890	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: 2026 RSU Award — 3,890 contracts (Direct); Common Stock — 3,200 shares (Direct)

Footnotes (2)

1. F1. Each RSU represents the right to receive, after vesting and upon settlement, one share of Common Stock of the Issuer.
2. F2. On May 6, 2026, the Reporting Person was granted an RSU Award in the amount of 3,890 RSUs. Subject to the terms of the award agreement, this award will fully vest on the date of the Issuer's 2027 Annual Meeting of Shareholders.

Key Figures

RSU award size: 3,890 RSUs Underlying common stock per RSU: 1 share of common stock Common stock held: 3,200 shares +1 more

4 metrics

RSU award size 3,890 RSUs Granted to director on May 6, 2026

Underlying common stock per RSU 1 share of common stock Each RSU converts into one share after vesting and settlement

Common stock held 3,200 shares Shares of common stock held directly after reported transactions

RSU exercise price 0.0000 per unit Disclosed conversion or exercise price for the 2026 RSU award

Key Terms

RSU, RSU Award, Annual Meeting of Shareholders

3 terms

RSU financial

"Each RSU represents the right to receive, after vesting and upon settlement, one share of Common Stock"

Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.

RSU Award financial

"On May 6, 2026, the Reporting Person was granted an RSU Award in the amount of 3,890 RSUs"

Annual Meeting of Shareholders financial

"this award will fully vest on the date of the Issuer's 2027 Annual Meeting of Shareholders"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Skyward Specialty Insurance Group (SKWD) report for Christopher Locke?

The company reported that director Christopher Locke received an award of 3,890 restricted stock units (RSUs). Each RSU converts into one share of common stock after vesting and settlement, making this a stock-based compensation grant rather than an open-market share purchase or sale.

How many RSUs did Christopher Locke receive from Skyward Specialty Insurance Group (SKWD)?

Christopher Locke was granted 3,890 RSUs. According to the disclosure, each RSU gives the right to receive one share of common stock after vesting, effectively tying his compensation more closely to the company’s share performance over time instead of providing immediate cash compensation.

When will Christopher Locke’s 3,890 RSUs at Skyward Specialty (SKWD) vest?

The 3,890 RSUs are scheduled to fully vest on the date of Skyward Specialty’s 2027 Annual Meeting of Shareholders. Vesting is subject to the terms of the award agreement, meaning conditions in that agreement must be satisfied before shares are actually delivered.

What does each RSU granted to Christopher Locke by Skyward Specialty (SKWD) represent?

Each RSU represents the right to receive one share of Skyward Specialty’s common stock after vesting and settlement. This structure aligns Locke’s potential future value with the company’s share price, without requiring him to pay an exercise price for the underlying shares.

How many Skyward Specialty (SKWD) common shares does Christopher Locke hold after this filing?

After the reported transactions, Christopher Locke holds 3,200 shares of common stock directly. In addition, he has 3,890 RSUs that are linked to common stock and will convert into shares only after they vest and are settled under the award’s terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/08/2026 - 04:32 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Peirce Christopher Locke

(Last) (First) (Middle)

800 GESSNER ROAD

SUITE 600

(Street)

HOUSTON TEXAS 77024

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Skyward Specialty Insurance Group, Inc. [ SKWD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								3,200	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
2026 RSU Award	(1)	05/06/2026		A		3,890		(2)	(2)	Common Stock	3,890	$0	3,890	D

Explanation of Responses:

1. Each RSU represents the right to receive, after vesting and upon settlement, one share of Common Stock of the Issuer.

2. On May 6, 2026, the Reporting Person was granted an RSU Award in the amount of 3,890 RSUs. Subject to the terms of the award agreement, this award will fully vest on the date of the Issuer's 2027 Annual Meeting of Shareholders.

	/s/ Stacy E. Skelton, Attorney-in-Fact	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)